JPRN-UMIN000040511
Completed
未知
Prevalence of HRR-related genes mutations and prognosis in metastatic castration resistant prostate cancer (mCRPC) patients in real world setting(ZENSHIN Study) - Prevalence of HRR-related genes mutations and prognosis in metastatic castration resistant prostate cancer (mCRPC) patients in real world setting(ZENSHIN Study)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- metastatic castration resistant prostate cancer (mCRPC)
- Sponsor
- AstraZeneca K.K.
- Enrollment
- 155
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who have failed HRR\-related gene mutation testing with the myChoice HRD plus in screening period. 2\. Patients who have an only FFPE primary tumor sample (primary or metastatic) with unbuffered formalin including acidic formalin. 3\. Patients who have taken an investigational medical product for prostate cancer from Jan 1st , 2014 to Dec 31st 2020\.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World SettingProstatic NeoplasmsNCT04425200AstraZeneca205
Completed
Not Applicable
HRR Prevalence in LatAm PROSPECT StudyCastration-resistant Prostate CancerNCT04962880AstraZeneca388
Completed
Not Applicable
Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian CancerEpithelial Ovarian CancerNCT04716374Hellenic Cooperative Oncology Group550
Completed
Not Applicable
Investigation of gene variants associated with resistance and susceptibility to HIV-1 infection in HIV-1 exposed but uninfected individuals with haemophilia A.HIV10047438NL-OMON34942Duke University50
Not yet recruiting
Not Applicable
Commonality of gene mutations in hypopharyngeal and esophageal cancerdouble cancer, hypopharyngeal and esophageal cancerJPRN-UMIN000044558Kobe University Graduate School of Medicine12